Kevin Lowell
Member
Kevin Lowell* represents clients in high-stakes litigation, government investigations and enforcement actions, and white collar defense, with an emphasis on health care fraud, False Claims Act (FCA) litigation, and regulatory enforcement. He joins Miller & Chevalier after more than a decade at the U.S. Department of Justice (DOJ), where he most recently served as Deputy Chief of the National Fraud Enforcement Division, Health Care Fraud Section. A first-chair trial lawyer, he led some of the government's most complex investigations.
Kevin draws on his DOJ experience to guide clients through government matters, from initial risk exposure through resolution, including subpoenas, internal investigations, and trial when needed, as well as compliance program design and implementation.
As a senior DOJ prosecutor, Kevin charged Operation Gold Rush, the largest healthcare fraud case in DOJ history, a $10.6 billion scheme. He spearheaded numerous investigations into fraud and Anti-Kickback Statute violations involving private equity-backed healthcare companies, health tech companies, hospice and home health agencies, laboratory testing companies, behavioral health providers, and medical device manufacturers, working closely with the Department of Health and Human Services Office of the Inspector General (HHS-OIG), the Centers for Medicare & Medicaid Services (CMS), state Medicaid agencies, health plan special investigation units (SIUs), and the Food and Drug Administration (FDA). Kevin leveraged data analytics to proactively identify case leads, supervised corporate resolutions, including a first-of-its kind charge against a medtech company for failing to report adverse events, and helped build DOJ's Corporate Whistleblower Awards Program.
Kevin's tenure at the DOJ spanned several of the government's most significant healthcare fraud initiatives of the past decade, giving him firsthand insight into how enforcement priorities have evolved. He joined the DOJ through the Attorney General's Honors Program, serving as a Trial Attorney in the Criminal Division's Money Laundering and Asset Recovery Section, Bank Integrity Unit, and its Fraud Section, where he prosecuted healthcare fraud and other white collar crimes. He also served as a Special Assistant U.S. Attorney in the Eastern District of Virginia, Public Corruption and Financial Crimes Unit.
Kevin was previously senior in-house counsel at a venture-backed company, counseling on risk mitigation and compliance, giving him a business-minded perspective on enforcement risk. He regularly speaks on enforcement trends and has lectured for the University of Pennsylvania, Georgetown University, and Cornell University.
*Practicing in DC under the direct supervision of active member of the DC Bar
Representative Engagements
Healthcare Fraud & Life Sciences Matters at the DOJ
- Charged Operation Gold Rush, the largest healthcare fraud case by intended loss amount ever brought by the DOJ, involving a $10.6 billion scheme to defraud Medicare and private health insurers through fraudulent claims and international money laundering.
- Led the investigation and resolution of the first corporate criminal charge against a medtech company for failing to report adverse events with intent to defraud the FDA, resulting in a three-year deferred prosecution agreement (DPA) over the concealment of two patient deaths linked to the company's blood-filtration device.
- Supervised the investigation and indictment of the principal operator of a foreign-based pharmaceutical company on charges of conspiracy to import misbranded drugs, including GLP-1 prescriptions, into the U.S.
- Supervised the investigation of a publicly traded company for systemically manipulating the Medicare Advantage risk-adjustment system, falsifying patient diagnoses to inflate risk scores and drive up federal reimbursement.
- Supervised the investigation of a national, venture-backed company for healthcare fraud arising from the provision of non-compliant remote patient monitoring (RPM) and chronic care management (CCM) services to skilled nursing facilities throughout the U.S.
- Supervised the investigation of a national Applied Behavior Analysis (ABA) therapy provider for systemically upcoding therapy sessions, billing for fabricated treatment hours and services never rendered, and fraudulently billing out-of-network claims to inflate reimbursement from private health insurers.
- Led the investigation and trial of the founder and CEO of a hospice and home health chain, tried alongside a co-defendant who was, at the time, a sitting city mayor, resulting in convictions in one of the largest combined hospice and home health fraud schemes ever criminally charged, involving over $150 million in false claims and patients falsely told they had less than six months to live.
- Led the investigation and indictment of a rheumatologist who falsely diagnosed numerous patients (including children as young as 13 and elderly and disabled adults) with rheumatoid arthritis and other life-long diseases, subjecting them to toxic chemotherapy treatments they did not need, in one of the largest rheumatology-based healthcare fraud cases brought by DOJ.
- Led the investigation and trial of the owner of a Northern Virginia healthcare company who used referring physicians' identities without their knowledge to bill for medically unnecessary sleep studies, convicted on healthcare fraud and tax charges arising from a scheme involving approximately $83 million in intended losses to Medicare and multiple private health insurers.
- Served as trial counsel in the trial of a psychiatrist convicted of healthcare fraud for his role in a $158 million partial hospitalization program (mental health) fraud scheme, one of multiple healthcare fraud matters Kevin has tried to verdict.
- Supervised the investigation of multiple companies that marketed and sold non-compliant, ERISA-exempt "limited medical benefit" plans as comprehensive major medical insurance, misrepresenting coverage and excluded services to induce consumers and employers to purchase deficient plans while collecting substantial premiums.
- Co-led the investigation resulting in the guilty plea of a former New York-based employee of a major U.S. bank who exploited their position to launder healthcare fraud proceeds on behalf of a transnational criminal organization.
Financial Crimes and Other Complex Fraud Matters at DOJ
- Led the DOJ's first nationally coordinated crypto fraud enforcement action, connected to more than $100 million in intended losses to retail investors and consumers.
- Led the investigation and guilty plea of the top U.S.-based promoter of a $2.4 billion Ponzi scheme (BitConnect) built on a fabricated cryptocurrency "trading bot" that defrauded numerous victims from dozens of countries, working closely with foreign investigative counterparts, and separately led the indictment of the scheme's founder.
- Led the investigation and guilty plea of a Los Angeles-based CEO of a tech company for securities fraud in connection with a $21 million fraudulent investment offering.
- Led the investigation and guilty plea of the Miami-based "head trader" of a purported trading platform in a global Ponzi scheme that took in approximately $100 million from investors.
- Served as co-counsel in the investigation of a U.S. subsidiary of a European global bank for obstructing its primary regulator, the Office of the Comptroller of the Currency (OCC), by concealing deficiencies in its anti-money laundering (AML) program, resulting in the subsidiary pleading guilty to obstruction charges and forfeiting $368 million.
- Served as co-counsel in the investigation of a U.K.-based global bank regarding a potential breach of its deferred prosecution agreement due to deficiencies in its Office of Foreign Assets Control (OFAC) and AML compliance programs, centered on the bank's processing of millions of dollars in transactions for the benefit of OFAC-sanctioned entities and individuals.
- Served as co-counsel in multiple other investigations of financial institutions (both domestic and international) for AML-, sanctions-, and fraud-related investigations.
- Led the investigation and subsequent guilty plea of a Napa, California-based CEO of a financial services firm for obstructing an Securities and Exchange Commission (SEC) investigation and court-appointed receivership regarding a billion-dollar Ponzi scheme by concealing funds subject to an SEC freeze order.
Government Experience
- Deputy Chief, National Fraud Enforcement Division, Health Care Fraud Section, DOJ, 2026
- Assistant Chief, Fraud Section, Criminal Division, DOJ, 2024 - 2025
- Trial Attorney, Fraud Section, Criminal Division, DOJ, 2016 - 2023
- Trial Attorney, Money Laundering and Asset Recovery Section, Bank Integrity Unit, Criminal Division, DOJ, 2013 - 2016
- Special Assistant United States Attorney, Financial Crimes and Public Corruption Unit (detail), U.S. Attorney's Office, Eastern District of Virginia, 2015
Rankings and Recognition
- DOJ Attorney General's Award for Fraud Prevention (Health Care), 2025
- National Health Care Anti-Fraud Association Investigation of the Year Award, 2025
- DOJ Assistant Attorney General's Award for Exceptional Service, 2025
- DOJ Assistant Attorney General's Award for Distinguished Service, 2025
- DOJ Assistant Attorney General's Award for Exceptional Service, 2022
- FinCEN Director's Award for Safeguarding the Financial System from Illicit Actors, 2020
- Inspectors General on Integrity and Efficiency’s Award for Excellence in Investigation, 2019
- DOJ Assistant Attorney General's Award for Exceptional Service, 2019
- FBI Award for Integrity and Commitment to Public Service, 2018
- DOJ Attorney General's Honors Program, 2013
Affiliations
- Chair, Executive Committee, West Coast Anti-Money Laundering Forum
Admissions
State Admissions
- Maryland
Court Admissions
- United States Court of Appeals for the Fourth Circuit
News and Events